Correction to: Glioblastoma multiforme: another potential application for ⁶⁸Ga-PSMA PET/CT as a guide for targeted therapy

Affiliations

¹ Department of Nuclear Medicine, Medical University of Warsaw, Banacha 1 a, 02-097, Warsaw, Poland. jolanta.kunikowska@wum.edu.pl.
² Department of Neuro-Oncology, The Maria Skłodowska Curie, Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.
³ Department of Nuclear Medicine, Medical University of Warsaw, Banacha 1 a, 02-097, Warsaw, Poland.

Published Erratum

Jolanta Kunikowska et al. Eur J Nucl Med Mol Imaging. 2020 Feb.

. 2020 Feb;47(2):514.

doi: 10.1007/s00259-019-04560-9.

¹ Department of Nuclear Medicine, Medical University of Warsaw, Banacha 1 a, 02-097, Warsaw, Poland. jolanta.kunikowska@wum.edu.pl.
² Department of Neuro-Oncology, The Maria Skłodowska Curie, Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.
³ Department of Nuclear Medicine, Medical University of Warsaw, Banacha 1 a, 02-097, Warsaw, Poland.

Abstract

The author names of the original version of this article were inadvertently interchanged. Correct author names are presented here.

Glioblastoma multiforme: another potential application for ⁶⁸Ga-PSMA PET/CT as a guide for targeted therapy.
Kunikowska J, Bartosz K, Leszek K. Kunikowska J, et al. Eur J Nucl Med Mol Imaging. 2018 May;45(5):886-887. doi: 10.1007/s00259-018-3934-2. Epub 2018 Jan 31. Eur J Nucl Med Mol Imaging. 2018. PMID: 29387926 No abstract available.